Neoadjuvant accelerated MVAC (AMVAC) in patients with muscle invasive bladder cancer: Results of a multicenter phase II study

被引：0
|
作者：
Plimack, Elizabeth R.
Hoffman-Censits, Jean H.
Viterbo, Rosalia
Greenberg, Richard Evan
Chen, David
Lallas, Costas D.
Trabulsi, Edouard John
Wong, Yu-Ning
Kutikov, Alexander
Lin, Jianqing
Duncan, Gail
Adair, Beth
Cione, Charlotte
O'Sullivan, Conor
Kilpatrick, Deborah
Ross, Eric A.
Boorjian, Stephen A.
Uzzo, Robert G.
Kelly, William Kevin
Hudes, Gary R.
机构：
[1] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
[2] Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA
[3] Mayo Clin, Rochester, MN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4526
引用
收藏
页数：1
相关论文
共 50 条
  • [31] A phase II study of toripalimab combined with gemcitabine-cisplatin as neoadjuvant therapy for patients with muscle-invasive bladder cancer (MIBC)
    Xu, Abai
    Xu, Peng
    Chen, Chunxiao
    Liu, Zhe
    Jiang, Ning
    Bi, Enguang
    Cao, Manming
    Chen, BinShen
    Liu, Chunxiao
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [32] Neoadjuvant dose-dense gemcitabine and cisplatin (DDGC) in patients (pts) with muscle-invasive bladder cancer (MIBC): Final results of a multicenter phase 11 study.
    Plimack, Elizabeth R.
    Hoffman-Censits, Jean H.
    Kutikov, Alexander
    Greenberg, Richard E.
    Bilusic, Marijo
    Chen, David Y. T.
    Viterbo, Rosalia
    Lallas, Costas D.
    Lin, Jianqing
    Trabulsi, Edouard John
    Geynisman, Daniel M.
    Kelly, William Kevin
    Smaldone, Marc C.
    Devarajan, Karthik
    Adaire-Halenda, Beth
    Cione, Charlotte
    Kilpatrick, Deborah
    Duncan, Gail
    Wong, Yu-Ning
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [33] Biodynamic prediction of neoadjuvant chemotherapy response: Results from a prospective multicenter study of predictive accuracy among muscle-invasive bladder cancer patients
    Laviana, Aaron A.
    Schiftan, Elizabeth G.
    Mashni, Joseph W.
    Large, Michael C.
    Kaimakliotis, Hristos Z.
    Nolte, David D.
    Turek, John J.
    An, Ran
    Morgan, Travis A.
    Chang, Sam S.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2023, 41 (06) : 295e9 - 295e17
  • [34] Adverse events during neoadjuvant chemotherapy for muscle invasive bladder cancer - a Swedish retrospective multicenter study
    Eriksson, V
    Holmlund, J.
    Wiberg, E.
    Johansson, M.
    Huge, Y.
    Alamdari, F.
    Svensson, J.
    Aljabery, F.
    Sherif, A.
    SCANDINAVIAN JOURNAL OF UROLOGY, 2023, 58 : 19 - 20
  • [35] Adverse events during neoadjuvant chemotherapy for muscle invasive bladder cancer - a Swedish retrospective multicenter study
    Eriksson, V
    Holmlund, J.
    Wiberg, E.
    Johansson, M.
    Huge, Y. A. M.
    Alamdari, F.
    Svensson, J.
    Aljabery, F.
    Sherif, A. M.
    EUROPEAN UROLOGY, 2024, 85 : S1352 - S1352
  • [36] A Phase II Trial of Neoadjuvant Erlotinib in Patients With Muscle-Invasive Bladder Cancer Undergoing Radical Cystectomy: Clinical and Pathological Results Editorial Comment
    Wood, David P.
    JOURNAL OF UROLOGY, 2011, 185 (03): : 811 - 812
  • [37] Phase II study of neoadjuvant chemotherapy with four cycles of dose-dense MVAC followed by radical cystectomy in Korean patients with muscle-invasive or locally advanced urothelial carcinoma of bladder
    Park, Kwonoh
    Lee, Hyun Jung
    Kim, Tae Un
    Ryu, Hwaseong
    Ki, Yong Kan
    Hong, Yun Jeong
    Nam, Jong Kil
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2023, 19 (06) : 739 - 746
  • [38] NEOADJUVANT CHEMOTHERAPY IN MUSCLE INVASIVE BLADDER CANCER
    Hazhir, Samad
    INTERNATIONAL JOURNAL OF UROLOGY, 2014, 21 : A54 - A54
  • [39] Neoadjuvant chemotherapy in muscle invasive bladder cancer
    Suer, Evren
    Turkolmez, Kadir
    UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2012, 11 (01): : 74 - 78
  • [40] Long-term results of a phase II study of synchronous chemoradiotherapy in advanced muscle invasive bladder cancer
    S A Hussain
    D D Stocken
    D R Peake
    J G Glaholm
    A Zarkar
    D M A Wallace
    N D James
    British Journal of Cancer, 2004, 90 : 2106 - 2111
12345